Register entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- India
Authorisation
Registered operations
Active ingredient (API) manufacture1Labelling1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| RUBAMIN PRIVATE LIMITED | R.s. No 115, Village Pratappura, Halol, Panchmahal, Gujarat 389350, India (IND) | Active ingredient (API) manufacture, Labelling, Packaging | 3012075440955415688 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Zinc Oxide 25 | bead | 87620-001BULK INGREDIENT |
Neighbours
Registered in the same town
1- Alembic Pharmaceuticals LimitedPANCHMAHAL, IND; Panchmahal, IND · 3 sites
Compare
Comparable companies in India
- Somerset Therapeutics Private Limited1 site · 187 NDC
- Bionpharma Inc.1 site · 181 NDC
- NURAY CHEMICALS PRIVATE LIMITED1 site · 105 NDC
- Jubilant Biosys Limited1 site · 94 NDC
- Xiromed LLC1 site · 94 NDC
- CAPLIN STERILES LIMITED1 site · 88 NDC
- Maithri Drugs Private Limited1 site · 80 NDC
- MSN Pharmachem Private Limited1 site · 54 NDC
- STHREE CHEMICALS PRIVATE LIMITED1 site · 52 NDC
- UMEDICA LABORATORIES PRIVATE LIMITED1 site · 52 NDC
Enquiry
Common questions
- Is RUBAMIN PRIVATE LIMITED FDA approved?
- RUBAMIN PRIVATE LIMITED holds 1 FDA-registered establishment in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are RUBAMIN PRIVATE LIMITED's drugs manufactured?
- The FDA register lists Panchmahal. Registered operations: active ingredient (API) manufacture, labelling, packaging.
- What drugs does RUBAMIN PRIVATE LIMITED make?
- 1 product is listed under RUBAMIN PRIVATE LIMITED in the openFDA NDC Directory, most often as bead. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.